Search
Loading Complete
Challice Lee Bonifant

Challice Lee Bonifant, MD, PhD

Pediatric Medical OncologyPediatric Cellular Therapy

Accepting New Patients

Highlights

Age Groups Seen

  • Infant 0-2
  • Child 3-12
  • Adolescent 13-17

Languages

  • English

In-Network Plans

View All Accepted Plans (12)

Gender

Female

Johns Hopkins Affiliations:

  • Johns Hopkins School of Medicine Faculty

About Challice Lee Bonifant

Primary Academic Title

Associate Professor of Oncology

Johns Hopkins Physician

Logo for Johns Hopkins Physician

Background

Dr. Bonifant is a pediatric oncologist on the blood and marrow transplantation team at the Sidney Kimmel Comprehensive Cancer Center and an Assistant Professor of Pediatric Oncology at the Johns Hopkins University School of Medicine. She is also a member of the Bloomberg-Kimmel Institute for Immunotherapy. Her clinical specialty is stem cell transplantation for high-risk leukemias.

Her research interests are in the areas of immunotherapy of cancer and malignant hematology. Currently, her research focuses on design and development of immune therapies as a treatment for poor-prognosis cancers, including development of engineered cellular immunotherapies for the treatment of Acute Myeloid Leukemia.

Dr. Bonifant is a graduate of Wake Forest University and Georgetown University. She completed her Pediatric and Hematology/Oncology training at Johns Hopkins and at Baylor College of Medicine. Prior to her appointment at Johns Hopkins, she was an Assistant Professor in Pediatrics-Hematology/Oncology at the University of Michigan.

Find a Clinical Trial

View all trials by this principal investigator.

Additional Academic Titles

Associate Professor of Pediatrics

Research Interests

engineered cellular immunotherapies for the treatment of Acute Myeloid Leukemia, Immunotherapy of cancer, malignant hematology

Selected Publications

  • Bonifant CL, Jackson HJ, Brentjens RJ, Curran KJ. Toxicity and management in CAR T-cell therapy. Molecular Therapy Oncolytics. 2016; 3:16011.

  • Bonifant CL, Szoor A, Torres D, Joseph N, Velasquez MP, Iwahori K, Gaikwad A, Nguyen P, Arber C, Song XT, Redell M, Gottschalk S. CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia. Molecular Therapy: The Journal of the American Society of Gene Therapy. 2016; 24(9):1615-26.

  • Bonifant CL, Velasquez MP, Gottschalk S. Advances in immunotherapy for pediatric acute myeloid leukemia. Expert Opinion on Biological Therapy. 2018; 18(1):51-63.

  • Krawczyk E, Zolov SN, Huang K, Bonifant CL. T-cell Activity against AML Improved by Dual-Targeted T Cells Stimulated through T-cell and IL7 Receptors. Cancer Immunology Research. 2019; 7(4):683-692.

  • Zolov SN, Rietberg SP, Bonifant CL. Programmed cell death protein 1 activation preferentially inhibits CD28.CAR-T cells. Cytotherapy. 2018; 20(10):1259-1266.

Patents

  • Combination CD123 and C-type Lectin Molecule 1 Targeted T cells for Acute Myeloid Leukemia (Co-Inventor), US Provisional Patent Application No. 62/398,859, PCT application US2017/052989
  • Chimeric Antigen Receptors Targeting Abnormal Glycobiology (Co-inventor), US Provisional Application No. 62/802,001
  • Chimeric Antigen Receptor Comprised of CD123 Binding Domain and IL-7 Intracellular Signaling Domain, US Provisional Patent Application No. 16/644,900, PCT application No. 16/358,253

Honors

2018 Damon Runyon-Jake Wetchler Award for Pediatric Innovation, Damon Runyon Foundation-Jake Wetchler Foundation, 1/1/18

Memberships

  • American Academy of Pediatrics
  • American Society of Hematology
  • American Society of Bone Marrow Transplantation

Locations

  1. Johns Hopkins Children's Center

Expertise

Education

  • Fellowship: Texas Children's Hospital, Pediatric Hematology-Oncology, 2015
  • Residency: Johns Hopkins University School of Medicine, Pediatrics, 2012
  • Graduate School: Georgetown University, PhD, 2009
  • Medical Education: Georgetown University School of Medicine, MD, 2009

Board Certifications

  • Pediatric Hematology-Oncology: American Board of Pediatrics, 2017
  • Pediatrics: American Board of Pediatrics, 2014

Insurance

Please contact the location directly to confirm your health plan is accepted.
Search plans
  • Aetna
  • CareFirst
  • Cigna
  • First Health
  • Geisinger Health Plan
  • HealthSmart/Accel
  • Johns Hopkins Health Plans
  • MultiPlan
  • Pennsylvania's Preferred Health Networks (PPHN)
  • Point Comfort Underwriters
  • Private Healthcare Systems (PHCS)
  • Veteran Affairs Community Care Network (Optum-VACCN)